Cheminformatic Tools and Databases for Pharmacology

session 71946 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
RALOXIFENE

RALOXIFENE


ATC G03XC01

GENITO
TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
ANTINEOPLASTIC
ANTIHYPOCALCEMIC AGENTS
BONE DENSITY CONSERVATION AGENTS
ESTROGEN RECEPTOR AGONIST/ANTAGONIST

ORAL

Cmax 1.05 NANOMOLAR

F 2 PERCENT

VD 152620 LITER (65 KILOGRAM)

PPB 95 PERCENT

Cl 2866 LITER / HOUR (65 KILOGRAM)

HT 27.7 HOUR

SOLUBILITY SLIGHTLY SOLUBLE IN WATER

ESTROGEN RECEPTOR BETA

PDB 1ERR (HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE)

LIGAND CODE = RAL (link to the list of PDB complexes)

Download experimental 3D coordinates of RAL with added hydrogens

ESTROGEN RECEPTOR P03372 ESTROGEN RECEPTOR HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3A NR3A1EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |